NNNN Anbio Biotechnology Earnings and EPS analysis

Relative Growth: Rel. Growth: 22

Relative Strength: Rel. Strength: 2

Relative Valuation: Rel. Valuation: 26

Relative Profitability: Rel. Profitability: 99

EPS in 2026 (TTM): $0.15

Last Report Period Date: Dec 31, 2025

Based on the company's latest reports for December 2025, the current 12-month EPS is $0.15. Anbio Biotechnology's earnings per share in 2025 was reported at $0.15, marking a rise from $0.06 in 2024.

NNNN earnings history

Historical annual and quarterly earnings per share (EPS) data for Anbio Biotechnology

EPS (TTM)

$0.15

Anbio Biotechnology had an yealy earnings per share of $0.15, showing a rise of 150% from $0.06 recorded in 2024. The trailing twelve months EPS for NNNN is $0.15 as of December 2025. Anbio Biotechnology's full-year EPS for 2024 was $0.06, a 45.5% decline compared to the previous year.

NNNN earnings chart

NNNN EPS growth history

Earnings per share growth rates over time

EPS growth YoY

150%

EPS growth 3Y avg

-98.9%

EPS growth 5Y avg

N/A

During the past three years, NNNN registered an average yearly EPS growth of -98.9%.

NNNN Earnings Waterfall

Breakdown of revenue, profit and net income for Anbio Biotechnology

NNNN Earnings vs Peers

What are the earnings of NNNN compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
BSX Boston Scientific Corp	18.36	55.6%	63.3%	N/A
ZBH Zimmer Biomet Holdings Inc	23.6	-20%	47.9%	N/A
STE STERIS plc	26.86	27.7%	95.3%	11.3%
ABT Abbott Laboratories	28.71	-51.4%	-1.8%	8.2%
TMO Thermo Fisher Scientific Inc	31.19	7.2%	0%	2%
SYK Stryker Corp	37.79	8%	10.9%	14.8%
ISRG Intuitive Surgical Inc	38.22	22.3%	29.1%	21.5%
BDX Becton Dickinson & Co	39.58	-0.9%	-0.6%	16.2%
EW Edwards Lifesciences Corp	43.72	-73.6%	-9.2%	6.9%
NNNN Anbio Biotechnology	66	150%	-98.9%	N/A

All data is based on quarterly TTM periods, unless otherwise specified.